Product Information
BUSPIRONE HCL 15 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.0423 per EA under NDC 64380074318. Its NADAC has been published 497 times since Jan 28, 2015.
FDA first approved this application on Aug 25, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380074318
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202330FDA Approved
8/25/2014
TE Code
AB
On Market Since
6/30/2015
Price Statistics
The NADAC for BUSPIRONE HCL 15 MG TABLET has been published 497 times since Jan 28, 2015, and over the history we have for it it has declined 52.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0423 per EA |
|---|---|
| All-time high | $0.0954 (May 13, 2015) |
| All-time low | $0.0359 (Nov 20, 2024) |
| 52-week high | $0.0485 |
| 52-week low | $0.0423 |
| Median price | $0.0535 |
| Average price | $0.0609 |
| Largest weekly change | -29.4% (Nov 20, 2024) |
| Weeks tracked | 497 |
| Tracking since | Jan 28, 2015 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 15 MG TABLET, manufactured by Strides Pharma Inc., is $0.0423 per EA (NDC 64380074318), effective Aug 19, 2026.
How has the price of BUSPIRONE HCL 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 15 MG TABLET has declined 52.8%. It has been tracked across 497 weekly CMS publications since Jan 28, 2015.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 15 MG TABLET?
Since Jan 28, 2015, the NADAC for BUSPIRONE HCL 15 MG TABLET has ranged from a low of $0.0359 (Nov 20, 2024) to a high of $0.0954 (May 13, 2015), with a median of $0.0535 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 15 MG TABLET?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUSPIRONE HCL 15 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BUSPIRONE HCL 15 MG TABLET?
BUSPIRONE HCL 15 MG TABLET (NDC 64380074318) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.